News
BLRX
2.428
-2.09%
-0.052
Weekly Report: what happened at BLRX last week (0914-0918)?
Weekly Report · 1d ago
Weekly Report: what happened at BLRX last week (0907-0911)?
Weekly Report · 09/14 09:49
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 09/10 12:06
BioLineRx And Hemispherian To Present GLIX1 Data At EANO 2026; Stock Up
NASDAQ · 09/10 12:01
BioLineRx and Hemispherian to Showcase GLIX1 Glioblastoma Data and Trial Design at EANO 2026
TipRanks · 09/10 11:28
BioLineRx And Hemispherian To Present Preclinical Efficacy Of GLIX1 In Orthotopic Glioblastoma Models, At 21st Meeting Of EANO 2026
Benzinga · 09/10 11:11
BioLineRx and Hemispherian AS to Present Encouraging GLIX1 Preclinical Efficacy Data and its Phase 1/2a Trial Design at the 21st Meeting of the European Association of Neuro-Oncology (EANO 2026)
PR Newswire · 09/10 11:00
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 09/09 21:06
Weekly Report: what happened at BLRX last week (0831-0904)?
Weekly Report · 09/07 09:45
Joseph Pantginis Reiterates Buy on Bioline RX as GLIX1 and CheMo4METPANC Advance and APHEXDA Royalties Support Funding Through 1H 2027
TipRanks · 09/01 06:45
Lifeward Names Josh Hexter Interim CEO, Rami Aviram As CFO
NASDAQ · 09/01 02:45
BioLineRx Earnings Call Highlights GLIX1 Momentum
TipRanks · 09/01 00:07
Midday Fly By: Aon buying USI, Lilly to acquire Merida
TipRanks · 08/31 16:01
BioLineRx Raises $3.75 Million in August Registered Direct Offering and Warrant Deal
TipRanks · 08/31 14:57
Morning Movers: SAIC jumps following FY27 guidance hike
TipRanks · 08/31 12:55
BioLineRx Advances GLIX1 Oncology Program and Posts Q2 2026 Results
TipRanks · 08/31 11:47
BioLineRx reports Q2 EPS 0c vs 0c last year
TipRanks · 08/31 11:10
Options Volatility and Implied Earnings Moves Today, August 31, 2026
TipRanks · 08/31 11:05
BioLineRx GAAP EPS of $0.00, revenue of $0.3M
Seeking Alpha · 08/31 11:02
BioLine Rx Q2 Sales $294.000K Miss $500.000K Estimate
Benzinga · 08/31 11:01
More
Webull provides a variety of real-time BLRX stock news. You can receive the latest news about Biolinerx through multiple platforms. This information may help you make smarter investment decisions.
About BLRX
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.